Preventing breast cancer just got easier. Will more women give these drugs a try?
Breast cancer will strike 1 in 8 women in her lifetime. But women who face an increased risk of being […]
» Read moreEveryone is talking about Rachel McAdams breast-pumping magazine photoshoot — and for good reason. This shot is fierce. The image was taken (and shared) […] Metastatic breast cancers treated with hormone therapy can become treatment-resistant when they acquire mutations in the human epidermal growth factor […] Regular breast cancer checks for women over 30 could save 3,500 lives, researchers say Current NHS policy invites woman aged […] Uncovering a novel mechanism that promotes growth of breast cancer bone metastasis has revealed a potential Achilles’ heel for these […] Researchers from Karolinska Institutet in Sweden have identified a protein that determines the identity and invasive properties of breast cancer […] Patient studies of a new sensing device have proved it can provide early warning of the potential failure of breast […] MONDAY, Oct. 22, 2018 — For patients with metastatic triple-negative breast cancer, atezolizumab plus nanoparticle albumin-bound (nab)-paclitaxel prolongs progression-free survival […] Women with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower risk of cardiac toxicity with […] Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the aromatase inhibitor letrozole significantly increases disease-free […]
Racael McAdams' Glam Breast Pumping Magazine Shoot is Glorious
HER2 mutations can cause treatment resistance in metastatic ER-positive breast cancer
Regular breast cancer checks for over 30 could save 3,500 lives
A novel strategy to potentially reduce breast cancer bone metastasis
Breast cancer cells become invasive by changing their identity
New wireless device can aid recovery of breast cancer patients
Chemoimmunotherapy Ups Survival in Triple-Negative Breast Cancer
HER2+ early breast cancers where shorter-course trastuzumab could be an option
Zoledronic acid improves disease-free survival in premenopausal HR+ early breast cancer
